Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Anticancer Research|February 27, 2022
Is Preoperative Spirometry Necessary for Gastrointestinal Cancer Surgery?Masato Mitsuda, Hiroki Shimizu, Yoshiaki Kuriu, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 3, 2023
[Reasonable Surgery for Sigmoid Colon Cancer with Asymptomatic Celiac Artery Stenosis and Superior Mesenteric Artery Stenosis-A Case Report]Yudai Nakabayashi, Jun Kiuchi, Yoshiaki Kuriu, et al.Journal of Gastroenterology|February 2, 2025
Functions and clinical significance of KCNB1 in esophageal squamous cell carcinomaAtsuki Ota, Atsushi Shiozaki, Hiroki Shimizu, et al.Oncology Letters|June 29, 2022
Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapyHiroyuki Inoue, Atsushi Shiozaki, Hitoshi Fujiwara, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 30, 2023
Preoperative oral antibiotic administration in patients undergoing curative resection with stoma creation for colorectal cancer: effectiveness in preventing surgical site infection and the possibility of peristomal candidiasis induced by enterobacterial alterationJun Kiuchi, Yoshiaki Kuriu, Tomohiro Arita, et al.Oncotarget|October 17, 2015
Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinomaHiroki Kobayashi, Shuhei Komatsu, Daisuke Ichikawa, et al.Carcinogenesis|December 12, 2017
Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinomaTaisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, et al.International Journal of Clinical Oncology|May 11, 2017
Monitoring with sensitive tumor markers contributes to decision-making and better prognosis in gastric cancer patients with peritoneal recurrenceTakuma Ohashi, Shuhei Komatsu, Daisuke Ichikawa, et al.Cancer Science|May 16, 2023
Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancerYusuke Takashima, Shuhei Komatsu, Takuma Ohashi, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 12, 2022
Impact of the preoperative clinical N stage on the prognosis of patients with colon cancerWataru Takaki, Tomohiro Arita, Yoshiaki Kuriu, et al.Pageof 10